The Changing Biopharma Risk Equation

September 21, 2016
The Economist Intelligence Unit

This paper, which incorporates the results of a survey of 254 pharmaceutical executives worldwide and a range of interviews with industry experts, explores global pharmaceutical companies' growth strategies and their plans for managing the associated risks.